Matches in Wikidata for { <http://www.wikidata.org/entity/Q91938160> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91938160 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91938160 description "scientific article published on 14 April 2020" @default.
- Q91938160 description "wetenschappelijk artikel" @default.
- Q91938160 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91938160 name "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 name "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 type Item @default.
- Q91938160 label "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 label "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 prefLabel "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 prefLabel "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 P1433 Q91938160-FAD6FD22-1FCC-48A0-BEA8-B6E7F2B763E8 @default.
- Q91938160 P1476 Q91938160-52C80CAF-7BBB-4FB2-B50C-096CE5210E1A @default.
- Q91938160 P2093 Q91938160-7E1BC471-700B-4EF7-BA27-EC9596C8BC75 @default.
- Q91938160 P2093 Q91938160-9ED9FA09-1521-4534-B10D-B69E0EEC4EFD @default.
- Q91938160 P2860 Q91938160-F088F0D4-EF4B-441B-9C4C-28F2F97ABAA6 @default.
- Q91938160 P31 Q91938160-3D0BD493-DDC8-4878-9685-19227283C53D @default.
- Q91938160 P356 Q91938160-49E2C086-452D-4F87-97CC-8F3B74FB8992 @default.
- Q91938160 P4510 Q91938160-314A9562-F9CD-4D48-9528-BE9488425171 @default.
- Q91938160 P50 Q91938160-56D90D90-D5C9-43BE-B86F-A7E9BB6A7F04 @default.
- Q91938160 P50 Q91938160-6AC3B8E8-BDCE-4182-B99C-F1BC38E0C387 @default.
- Q91938160 P50 Q91938160-FBE9801B-D80B-4837-B413-B41AE431ED63 @default.
- Q91938160 P577 Q91938160-D0561012-6632-4849-AFD4-D2221DFEF43B @default.
- Q91938160 P698 Q91938160-559F5940-F9A0-4350-A6D5-AFCC84911B1E @default.
- Q91938160 P921 Q91938160-3BECC7A4-664B-4F12-9610-EC143A2EE50E @default.
- Q91938160 P932 Q91938160-5ABF252C-19AD-4EA5-9ABC-228A793613A2 @default.
- Q91938160 P356 CAS.14414 @default.
- Q91938160 P698 32291856 @default.
- Q91938160 P1433 Q326125 @default.
- Q91938160 P1476 "Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression" @default.
- Q91938160 P2093 "Jo Kitawaki" @default.
- Q91938160 P2093 "Yoshihiro Sowa" @default.
- Q91938160 P2860 Q36128435 @default.
- Q91938160 P31 Q13442814 @default.
- Q91938160 P356 "10.1111/CAS.14414" @default.
- Q91938160 P4510 Q1659584 @default.
- Q91938160 P50 Q88646716 @default.
- Q91938160 P50 Q91938153 @default.
- Q91938160 P50 Q91938157 @default.
- Q91938160 P577 "2020-04-14T00:00:00Z" @default.
- Q91938160 P698 "32291856" @default.
- Q91938160 P921 Q172341 @default.
- Q91938160 P932 "7293078" @default.